Wells Fargo & Company Daxor Corp Transaction History

Wells Fargo & Company

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.86 - $9.7 $0 - $0	0 New	0 $0
Q2 2024 Aug 13, 2024	BUY	$0.0 - $9.94 $0 - $0	0 New	0 $0
Q1 2024 May 10, 2024	BUY	$7.19 - $10.03 $0 - $0	0 New	0 $0
Q4 2023 Feb 09, 2024	BUY	$7.26 - $9.6 $0 - $0	0 New	0 $0
Q3 2023 Nov 13, 2023	BUY	$9.03 - $10.15 $0 - $0	0 New	0 $0
Q2 2023 Aug 15, 2023	BUY	$9.51 - $13.03 $0 - $0	0 New	0 $0
Q1 2023 May 12, 2023	BUY	$8.25 - $11.23 $0 - $0	0 New	0 $0
Q4 2022 Feb 13, 2023	BUY	$9.1 - $13.63 $0 - $0	0 New	0 $0
Q2 2022 Aug 12, 2022	BUY	$10.62 - $13.21 $6,371 - $7,926	600 New	600 $8,000
Q1 2022 May 16, 2022	SELL	$10.51 - $11.52 $3,026 - $3,317	-288 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.9 - $14.15 $2,670 - $4,245	-300 Reduced 51.02%	288 $3,000
Q1 2021 May 13, 2021	BUY	$11.02 - $13.86 $3,306 - $4,158	300 Added 104.17%	588 $7,000
Q1 2020 May 14, 2020	BUY	$8.6 - $14.25 $2,476 - $4,104	288 New	288 $4,000

87.3K

Ticker DXR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 4,041,670
Market Cap $36.4M
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.